Your browser doesn't support javascript.
loading
Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK Positive.
Ahrendsen, Jared T; Ta, Robert; Li, Jingwei; Weinberg, Olga K; Ferry, Judith A; Hasserjian, Robert P; Meredith, David M; Varma, Hemant; Sadigh, Sam; Michaels, Phillip D.
Afiliação
  • Ahrendsen JT; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Ta R; Oklahoma City Office of the Chief Medical Examiner, Oklahoma City, OK, USA.
  • Li J; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Weinberg OK; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Ferry JA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Hasserjian RP; University of Texas-Southwestern Medical Center, Dallas, TX, USA.
  • Meredith DM; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Varma H; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Sadigh S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Michaels PD; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Am J Clin Pathol ; 158(2): 300-310, 2022 08 04.
Article em En | MEDLINE | ID: mdl-35460414
ABSTRACT

OBJECTIVES:

Primary central nervous system anaplastic large cell lymphoma, anaplastic lymphoma kinase positive (primary CNS ALCL, ALK+) is a rare CNS lymphoma whose description is limited to case reports. These tumors have a variable clinical course, and prognosis is primarily determined by age. We present the largest case series to date of primary CNS ALCL, ALK+, with observational data.

METHODS:

A retrospective search of multiple academic centers was performed to identify cases of primary CNS ALCL, ALK+. We also performed a review of published cases of primary CNS ALCL, ALK+. Clinical history, radiography, pathology, and genetic testing data were obtained to determine the prognostic implications in the context of clinical course.

RESULTS:

We identified three cases of primary CNS ALCL, ALK+ from our databases. A literature review identified 30 published reports of 31 individual cases. Clinical features for the combined 34 cases included a median age of 18.5 years, with a male to female ratio of 4.71, and the most common symptom was headache. Genetic studies demonstrated an ALK rearrangement by fluorescence in situ hybridization, and a gene fusion assay confirmed an NPM1-ALK gene fusion in one case.

CONCLUSIONS:

We present the largest case series to date of a rare primary CNS lymphoma with additional diagnostic and clinical information.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Anaplásico de Células Grandes Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Anaplásico de Células Grandes Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article